IMMEDIATE-RELEASE AND SUSTAINED-RELEASE PHARMACEUTICAL PREPARATION INCLUDING ITOPRIDE HYDROCHLORIDE

The present invention provides a pharmaceutical preparation comprising: (a) a sustained-release part including itopride or a pharmaceutically acceptable salt thereof, a sustained-release polymer, a CO2 supply component, an organic acid and an optional pharmaceutically acceptable filler; and (b) an i...

Full description

Saved in:
Bibliographic Details
Main Authors SUNG, Yun Jin, LEE, Bong-Sang, KIM, Seung Kyun, JEON, Hong Ryeol
Format Patent
LanguageEnglish
French
Korean
Published 23.08.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a pharmaceutical preparation comprising: (a) a sustained-release part including itopride or a pharmaceutically acceptable salt thereof, a sustained-release polymer, a CO2 supply component, an organic acid and an optional pharmaceutically acceptable filler; and (b) an immediate-release part including itopride or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable filler. The present invention is taken once a day and thus can increase drug compliance. La présente invention concerne une préparation pharmaceutique qui comporte : (a) une partie à libération prolongée comprenant de l'itopride ou un sel de qualité pharmaceutique de celui-ci, un polymère à libération prolongée, un constituant fournissant du CO2, un acide organique, et facultativement une charge de qualité pharmaceutique; (b) une partie à libération immédiate comprenant de l'itopride ou un sel de qualité pharmaceutique de celui-ci, et une charge de qualité pharmaceutique. La présente invention est prise une fois par jour et peut ainsi augmenter l'observance de la prise du médicament. 본 발명은 (a) 이토프리드 또는 이의 약학적으로 허용가능한 염; 서방성 고분자; CO2 공급성분; 유기산; 및 임의의 약학적으로 허용가능한 충진제를 포함하는 서방성부, 및 (b) 이토프리드 또는 이의 약학적으로 허용가능한 염; 및 약학적으로 허용가능한 충진제를 포함하는 속방성부를 포함하는 약학적 제제를 제공한다. 본 발명은 1일 1회 투여로 복약 순응도를 높일 수 있다.
Bibliography:Application Number: WO2018KR02079